Preservatives - Daily Dose of Benzalkonium Chloride in the Treatment of Glaucoma from the Patient's Perspective
Abstract
Nowadays, in indication of local anti-glaucoma treatment the physician can choose from several tens of active ingredients and concentrations in eye drops available on the market. We make our choice taking course of the disease, topical clinical record file, and our clinical experience into account, but we also pay attention to the patient's subjective acceptance of the previous treatment.
The objective is to find such a treatment that would guarantee the preservation of visual function as well as the quality of patient's life. The drug must be well-tolerated and the side effects (either general or local) must not deteriorate the patient's cooperation in the treatment regime.
The presence and composition of excipients play an important role here. We have reckoned with the daily dose of benzalkonium chloride (BAC) in the treatment of glaucoma.